Mereo BioPharma (MREO) EPS (Weighted Average and Diluted) (2023 - 2025)
Historic EPS (Weighted Average and Diluted) for Mereo BioPharma (MREO) over the last 3 years, with Q3 2025 value amounting to -$0.01.
- Mereo BioPharma's EPS (Weighted Average and Diluted) rose 5000.0% to -$0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.06, marking a year-over-year change of 0.0%. This contributed to the annual value of -$0.06 for FY2024, which is 4619.92% down from last year.
- According to the latest figures from Q3 2025, Mereo BioPharma's EPS (Weighted Average and Diluted) is -$0.01, which was up 5000.0% from -$0.02 recorded in Q2 2025.
- Over the past 5 years, Mereo BioPharma's EPS (Weighted Average and Diluted) peaked at -$0.01 during Q4 2024, and registered a low of -$0.02 during Q1 2023.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was -$0.01 (2023), whereas its average is -$0.01.
- Data for Mereo BioPharma's EPS (Weighted Average and Diluted) shows a peak YoY increase of 5000.0% (in 2024) and a maximum YoY decrease of 10000.0% (in 2024) over the last 5 years.
- Over the past 3 years, Mereo BioPharma's EPS (Weighted Average and Diluted) (Quarter) stood at -$0.01 in 2023, then rose by 4.74% to -$0.01 in 2024, then decreased by 4.97% to -$0.01 in 2025.
- Its EPS (Weighted Average and Diluted) stands at -$0.01 for Q3 2025, versus -$0.02 for Q2 2025 and -$0.02 for Q1 2025.